The Cobas AmpliPrep-Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples
✍ Scribed by Stéphane Chevaliez; Magali Bouvier-Alias; Laurent Castéra; Jean-Michel Pawlotsky
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 131 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
LT). Six patients (30%) with LF were not treated medically, of whom five had submassive necrosis on liver biopsy. Five of these six patients underwent transplantation and all but one survived. One could not undergo transplantation due to development of fatal cholangitis.
In conclusion, about 20% of patients with AIH have LF at initial presentation. A lower MELD score at admission (Յ 28), more severe hepatic fibrosis, and an early (within 4 days of steroid therapy) improvement or stabilization in serum bilirubin and INR identify those who are likely to respond to steroid therapy, and thus survive without LT. Our observations need further corroboration, but if confirmed, such a stratification strategy could optimize care of patients with AIH who present with LF.